Total Payments
$20,017
2024 Payments
$2,080
Companies
67
Transactions
1,104
Medicare Patients
16,613
Medicare Billing
$643,652
Payment Breakdown by Category
Food & Beverage$19,933 (99.6%)
Travel$77.50 (0.4%)
Education$6.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,933 | 1,102 | 99.6% |
| Travel and Lodging | $77.50 | 1 | 0.4% |
| Education | $6.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,811 | 166 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,109 | 100 | $0 (2024) |
| Allergan, Inc. | $1,856 | 97 | $0 (2022) |
| PFIZER INC. | $1,217 | 116 | $0 (2024) |
| Amgen Inc. | $1,050 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $972.57 | 48 | $0 (2024) |
| Lilly USA, LLC | $929.00 | 78 | $0 (2024) |
| GlaxoSmithKline, LLC. | $816.34 | 47 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $769.13 | 27 | $0 (2024) |
| Horizon Therapeutics plc | $667.25 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,080 | 114 | ABBVIE INC. ($707.40) |
| 2023 | $3,453 | 175 | ABBVIE INC. ($950.95) |
| 2022 | $3,294 | 187 | ABBVIE INC. ($727.85) |
| 2021 | $3,189 | 163 | AbbVie Inc. ($403.58) |
| 2020 | $2,253 | 114 | Allergan, Inc. ($418.95) |
| 2019 | $1,898 | 106 | AstraZeneca Pharmaceuticals LP ($292.04) |
| 2018 | $1,985 | 113 | AstraZeneca Pharmaceuticals LP ($276.78) |
| 2017 | $1,864 | 132 | PFIZER INC. ($292.54) |
All Payment Transactions
1,104 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Oncology | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: UROLOGY | ||||||
| 12/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.56 | General |
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 60 | 3,797 | 5,512 | $327,264 | $123,808 |
| 2022 | 54 | 3,950 | 5,387 | $315,980 | $124,608 |
| 2021 | 56 | 4,079 | 5,740 | $357,529 | $141,178 |
| 2020 | 61 | 4,787 | 6,685 | $466,058 | $254,058 |
Total Patients
16,613
Total Services
23,324
Medicare Billing
$643,652
Procedure Codes
231
All Medicare Procedures & Services
231 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 583 | $84,535 | $27,121 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 216 | 260 | $25,480 | $11,739 | 46.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 81 | $10,939 | $7,081 | 64.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $25,245 | $6,465 | 25.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $6,300 | $5,912 | 93.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 40 | $10,400 | $5,032 | 48.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 23 | 114 | $22,800 | $3,780 | 16.6% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 35 | 35 | $5,075 | $3,286 | 64.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 207 | 313 | $7,825 | $3,229 | 41.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 147 | 188 | $7,520 | $3,094 | 41.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 42 | $3,276 | $3,018 | 92.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 188 | 343 | $4,459 | $2,881 | 64.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 58 | 58 | $5,800 | $2,816 | 48.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 168 | 211 | $6,330 | $2,768 | 43.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 164 | 164 | $4,592 | $2,636 | 57.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 218 | 306 | $5,814 | $2,321 | 39.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $2,660 | $2,099 | 78.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 61 | 66 | $3,234 | $1,915 | 59.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 23 | 54 | $5,400 | $1,835 | 34.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 113 | 113 | $3,164 | $1,815 | 57.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 21 | $2,898 | $1,776 | 61.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 81 | 89 | $4,895 | $1,651 | 33.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 69 | 70 | $2,660 | $1,623 | 61.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 55 | $2,090 | $1,531 | 73.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 99 | 159 | $4,134 | $1,514 | 36.6% |
About Dr. Anna Parchman, MD
Dr. Anna Parchman, MD is a Family Medicine healthcare provider based in Hot Springs, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578565321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Parchman, MD has received a total of $20,017 in payments from pharmaceutical and medical device companies, with $2,080 received in 2024. These payments were reported across 1,104 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($19,933).
As a Medicare-enrolled provider, Parchman has provided services to 16,613 Medicare beneficiaries, totaling 23,324 services with total Medicare billing of $643,652. Data is available for 4 years (2020–2023), covering 231 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hot Springs, AR
- Active Since 08/11/2005
- Last Updated 09/27/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578565321
Products in Payments
- FARXIGA (Drug) $1,446
- VRAYLAR (Drug) $1,434
- BOTOX (Biological) $845.88
- UBRELVY (Drug) $762.84
- REXULTI (Drug) $501.99
- GEMTESA (Drug) $495.75
- TRELEGY ELLIPTA (Drug) $495.23
- ENTRESTO (Drug) $445.31
- XARELTO (Drug) $428.78
- Otezla (Drug) $347.51
- LINZESS (Drug) $332.12
- KRYSTEXXA (Biological) $329.47
- NURTEC ODT (Drug) $314.76
- XIFAXAN (Drug) $313.46
- Kerendia (Drug) $305.50
- Xofluza (Drug) $303.53
- ABILIFY MAINTENA (Drug) $300.76
- QULIPTA (Drug) $300.25
- SPRAVATO (Drug) $299.30
- LYRICA (Drug) $288.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hot Springs
Dr. Hunter Carrington, M.d, M.D
Family Medicine — Payments: $20,623
Family Medicine $20,623
Scott Anderson, D.o, D.O
Family Medicine — Payments: $13,513
Family Medicine $13,513
Robert Parrott, D.o, D.O
Family Medicine — Payments: $12,791
Family Medicine $12,791
Dr. Martin Koehn, M.d, M.D
Family Medicine — Payments: $11,985
Family Medicine $11,985
Jodi Sanson, Md, MD
Family Medicine — Payments: $9,880
Family Medicine $9,880
Dr. Halah Al-Dadah, M.d, M.D
Family Medicine — Payments: $9,774
Family Medicine $9,774